Skip Navigation

British Journal of Anaesthesia 2009 103(6):805-810; doi:10.1093/bja/aep297
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saravanan, P.
Right arrow Articles by Falter, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saravanan, P.
Right arrow Articles by Falter, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author [2009]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Impact of xenon anaesthesia in isolated cardiopulmonary bypass on very early leucocyte and platelet activation and clearance: a randomized, controlled study

P. Saravanan1,3,*, A. R. Exley2, K. Valchanov3, N. D. Casey4,5 and F. Falter3

1 Department of Anaesthetics, Blackpool Fylde and Wyre Hospitals NHS Foundation Trust, Whinney Heys Road, Blackpool FY3 8NR, UK
2 Immunology Laboratory, Department of Pathology,
3 Department of Anaesthesia and Intensive Care Medicine and
4 Department of Perfusion, Papworth Hospital NHS Foundation Trust, Cambridge CB23 3RE, UK
5 Department of Perfusion, BC Children's Hospital, 4480, Oak Street, Vancouver, Canada V6H 3V4

* Corresponding author. E-mail: dr.saravanan{at}bfwhospitals.nhs.uk

Background: Cardiopulmonary bypass (CPB) is associated with leucocyte and platelet activation and also organ dysfunction. Xenon has been found to have organ-protective effects. We therefore investigated the effect of isolated CPB on leucocyte and platelet activation and the efficacy of xenon in inhibiting these changes.

Methods: Isolated CPB was conducted according to strict standardized clinical criteria using blood from healthy volunteers. They were randomized to an air–oxygen mixture (control group) vs xenon–oxygen mixture (xenon group). Blood samples were drawn at 5, 15, 30, 60, and 90 min from commencement of circuits and analysed for haemoglobin concentrations, white cell, neutrophil, monocyte, lymphocyte, and platelet counts. Leucocyte and platelet activation and also complex formation were determined by measuring levels of CD14++ monocytes, CD16+ monocytes, platelet–monocyte complexes, and platelet–neutrophil complexes (PNC). Differences between and within the groups were analysed with Student's t-test.

Results: Biomarker levels were not different between the groups. The data were pooled to identify the effects of isolated bypass. The neutrophils, monocytes, platelets, CD14++ monocytes, and CD16+ monocytes decreased within 5 min of the bypass experiments, whereas the percentage of platelet–CD++ monocyte complexes and PNC increased.

Conclusions: Isolated CPB elicited rapid, substantial leucocyte and platelet activation, and xenon had no impact on inhibiting these changes.

Keywords: blood, platelets; blood, neutrophils; heart, cardiopulmonary bypass; immune response, suppression; special drugs, xenon


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.